Holmer S R, Riegger G A
Klinik und Poliklinik für Innere Medizin II, Universität Regensburg.
Herz. 1995 Oct;20(5):322-9.
Chronic mechanical stress of the heart by arterial hypertension is a primary cause of left ventricular hypertrophy. The cardiac renin-angiotensin system is often found activated in conditions of increased afterload or mechanical stress of myocytes. Cardiac expression of angiotensinogen and angiotensin-converting enzyme (ACE) is increased resulting in elevated cardiac angiotensin II formation. This has been demonstrated in stretched cardiac myocytes in vitro as well as in animal models of pressure overload hypertrophy (supravalvular aortic stenosis and spontaneously hypertensive rats) and in human pressure overload hypertrophy (aortic stenosis). Functional consequences of elevated angiotensin II levels may be vasoconstriction of the coronary vasculature and a deterioration of diastolic function of the hypertrophied heart. Local formation of angiotensin II may also have proliferative effects on cardiac myocytes and connective tissue cells. Angiotensin II may, thus, be an important factor causing development and progression of left ventricular hypertrophy by itself. Blockade of the renin-angiotensin system has been found to be an effective treatment of hypertensive heart disease, probably better than any other antihypertensive medication. Regression of left ventricular hypertrophy has been achieved by blockade of the angiotensin II pathway either by administration of an angiotensin-converting enzyme inhibitor or an angiotensin II type 1-receptor blocker. The animal model of supravalvular aortic stenosis has been used to show beneficial effects of blockade of the renin-angiotensin system on hypertrophy and survival. In this rat model regression of left ventricular hypertrophy by ACE-inhibition or angiotensin II type 1-receptor blockade could be demonstrated by serial echocardiographic analyses while afterload of the left ventricle was still elevated.(ABSTRACT TRUNCATED AT 250 WORDS)
动脉高血压引起的心脏慢性机械应力是左心室肥厚的主要原因。在心肌细胞后负荷增加或机械应力增加的情况下,心脏肾素-血管紧张素系统常常被激活。血管紧张素原和血管紧张素转换酶(ACE)的心脏表达增加,导致心脏中血管紧张素II的生成增加。这已在体外拉伸的心肌细胞以及压力超负荷肥大的动物模型(主动脉瓣上狭窄和自发性高血压大鼠)和人类压力超负荷肥大(主动脉狭窄)中得到证实。血管紧张素II水平升高的功能后果可能是冠状血管收缩以及肥厚心脏舒张功能恶化。血管紧张素II的局部生成也可能对心肌细胞和结缔组织细胞具有增殖作用。因此,血管紧张素II本身可能是导致左心室肥厚发生和进展的重要因素。已发现阻断肾素-血管紧张素系统是治疗高血压性心脏病的有效方法,可能比任何其他抗高血压药物都更好。通过给予血管紧张素转换酶抑制剂或血管紧张素II 1型受体阻滞剂阻断血管紧张素II途径,已实现左心室肥厚的消退。主动脉瓣上狭窄的动物模型已被用于显示阻断肾素-血管紧张素系统对肥厚和生存的有益作用。在这个大鼠模型中,通过连续超声心动图分析可以证明,在左心室后负荷仍然升高的情况下,ACE抑制或血管紧张素II 1型受体阻断可使左心室肥厚消退。(摘要截短于250字)